Manufacturing

The strategic investments expanding CDMO capabilities for HPAPIs and ADCs

Pharmaceutical Technology

Demand for HPAPIs and ADCs is accelerating, prompting CDMOs to invest to strengthen manufacturing capabilities for oncology.

Read full story

pharminent April 29, 2026 (Last updated: April 29, 2026)

Pharmaceutical Technology

Demand for HPAPIs and ADCs is accelerating, prompting CDMOs to invest to strengthen manufacturing capabilities for oncology.

Read full story